Trupanion (NASDAQ:TRUP) Upgraded by Piper Sandler to “Overweight” Rating

Trupanion (NASDAQ:TRUPGet Free Report) was upgraded by equities researchers at Piper Sandler from a “neutral” rating to an “overweight” rating in a note issued to investors on Thursday, Marketbeat reports. The firm presently has a $57.00 price objective on the financial services provider’s stock. Piper Sandler’s price objective indicates a potential upside of 16.56% from the company’s current price.

A number of other research firms also recently issued reports on TRUP. Northland Securities raised their target price on Trupanion from $45.00 to $50.00 and gave the stock a “market perform” rating in a research report on Thursday, October 31st. Stifel Nicolaus lifted their price objective on Trupanion from $42.00 to $44.00 and gave the stock a “hold” rating in a report on Monday, January 6th. Two research analysts have rated the stock with a hold rating, four have assigned a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat.com, Trupanion presently has an average rating of “Moderate Buy” and an average target price of $45.33.

View Our Latest Stock Report on TRUP

Trupanion Price Performance

Shares of NASDAQ:TRUP opened at $48.90 on Thursday. The company has a market capitalization of $2.07 billion, a P/E ratio of -152.81, a price-to-earnings-growth ratio of 8.11 and a beta of 1.61. The company’s 50-day moving average is $50.60 and its 200 day moving average is $45.97. The company has a debt-to-equity ratio of 0.40, a quick ratio of 1.66 and a current ratio of 1.66. Trupanion has a fifty-two week low of $19.69 and a fifty-two week high of $57.90.

Trupanion (NASDAQ:TRUPGet Free Report) last released its earnings results on Wednesday, October 30th. The financial services provider reported $0.03 earnings per share for the quarter, beating analysts’ consensus estimates of ($0.06) by $0.09. Trupanion had a negative net margin of 1.08% and a negative return on equity of 4.36%. The firm had revenue of $327.50 million for the quarter, compared to analysts’ expectations of $321.79 million. During the same period in the previous year, the company earned ($0.10) earnings per share. The company’s quarterly revenue was up 14.6% on a year-over-year basis. On average, equities research analysts forecast that Trupanion will post -0.2 earnings per share for the current year.

Insider Transactions at Trupanion

In other Trupanion news, CFO Fawwad Qureshi sold 9,867 shares of the firm’s stock in a transaction dated Friday, November 29th. The stock was sold at an average price of $53.08, for a total value of $523,740.36. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, SVP Emily Dreyer sold 900 shares of Trupanion stock in a transaction dated Monday, November 25th. The shares were sold at an average price of $54.55, for a total value of $49,095.00. Following the transaction, the senior vice president now directly owns 23,808 shares of the company’s stock, valued at $1,298,726.40. The trade was a 3.64 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 28,597 shares of company stock valued at $1,522,082 over the last three months. Company insiders own 5.50% of the company’s stock.

Institutional Trading of Trupanion

Institutional investors and hedge funds have recently bought and sold shares of the company. Quest Partners LLC bought a new position in shares of Trupanion in the third quarter worth $37,000. Wilmington Savings Fund Society FSB purchased a new position in Trupanion during the third quarter worth about $54,000. GAMMA Investing LLC increased its stake in Trupanion by 70.4% in the 3rd quarter. GAMMA Investing LLC now owns 1,442 shares of the financial services provider’s stock worth $61,000 after acquiring an additional 596 shares during the last quarter. KBC Group NV purchased a new stake in shares of Trupanion in the 4th quarter valued at about $75,000. Finally, R Squared Ltd bought a new stake in shares of Trupanion during the 4th quarter valued at about $79,000.

Trupanion Company Profile

(Get Free Report)

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.

Recommended Stories

Analyst Recommendations for Trupanion (NASDAQ:TRUP)

Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.